Find similar content

Source channel @githubtrending · Post #14731 · May 21

#cplusplus#high_performance#interior_point_method#linear_optimization#mixed_integer_programming#parallel#quadratic_programming#simplex HiGHS is a free, high-performance software that solves large and complex optimization problems like linear, quadratic, and mixed-integer programming. It works fast on many computers, including Linux, MacOS, and Windows, without needing extra software. You can use it through various programming languages like Python, C, C#, and Fortran, making it easy to integrate into your projects. HiGHS supports both serial and parallel computing, and it is advancing GPU acceleration for even faster solutions. This helps you efficiently find the best solutions for planning, scheduling, and decision-making problems in science, engineering, and business. Installation is straightforward, and detailed documentation is available to guide you[1][2][3][4]. https://github.com/ERGO-Code/HiGHS

Hashtags

#cplusplus #high_performance #interior_point_method #linear_optimization #mixed_integer_programming #parallel #quadratic_programming #simplex

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment